IOP Reduction by Timolol, Azopt, and Alphagan P

Introduction to IOP-Lowering Medications

• The American Academy of Ophthalmology recommends timolol 0.5% for IOP reduction, achieving approximately 7-9 mmHg (or 25-30% from baseline) reduction 1, 2

Timolol (Beta-Blocker)

• Timolol is the most potent IOP-lowering agent among these three medications, with an absolute IOP reduction of approximately 7-9 mmHg in clinical trials 1

Brimonidine/Alphagan P (Alpha-2 Agonist)

• Brimonidine 0.2% achieves approximately 4-6 mmHg IOP reduction, representing a 15-25% reduction from baseline 2

Comparative Efficacy

• Latanoprost is more effective than brimonidine in lowering IOP 3, 4, 5

Clinical Implementation Considerations

• The American Academy of Ophthalmology suggests checking IOP response within 2-4 weeks of initiating timolol to confirm adequate pressure reduction 1
• Timolol is contraindicated in patients with asthma, COPD, or bradycardia due to systemic beta-blockade effects 2
• Brimonidine has adverse effects, with approximately 20% of patients discontinuing due to adverse experiences, primarily ocular allergic reactions 2
• It is recommended to wait at least 5 minutes between different eye drops to prevent washout 1